Keywords: biotech, deals, boost, strong, pharma, activity, says
Biotech deals boost strong pharma M&A activity in 2001, says PwC
Article | 11 March 2002
A new report published by PricewaterhouseCoopers notes that the value ofpharmaceutical mergers and acquisitions announced in 2001 almost doubled to $61 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
